Findings suggest common salt activates anti-tumor cells

by Friederike Gawlik, Leibniz Institute for Natural Product Research and Infection BiologyImmune cells (purple and blue) attack tumor cells (red). Highly active CD8⁺ T cells treated with sodium chlori

Updated on: September 10,2024

Findings suggest common salt activates anti-tumor cells

by Friederike Gawlik, Leibniz Institute for Natural Product Research and Infection BiologyImmune cells (purple and blue) attack tumor cells (red). Highly active CD8⁺ T cells treated with sodium chlori

Updated on:September 10,2024

Researchers analyze cancer discrepancies among young Black men in the South

by Vinod Hopson,University of Texas Health Science Center at HoustonRegional Kaposi sarcoma incidence rate trends in non-Hispanic White men aged 20-34. Abbreviation: AAPC, average annual percent

Updated on: January 30,2024

Researchers analyze cancer discrepancies among young Black men in the South

by Vinod Hopson,University of Texas Health Science Center at HoustonRegional Kaposi sarcoma incidence rate trends in non-Hispanic White men aged 20-34. Abbreviation: AAPC, average annual percent

Updated on:January 30,2024

New circulating tumor DNA test measures multiple markers to detect cancer early

byeLifeCredit: CC0 Public DomainResearchers have developed a method that simultaneously measures different cancer-specific hallmarks of DNA circulating in the blood, aiding early detection and l

Updated on: January 12,2024

New circulating tumor DNA test measures multiple markers to detect cancer early

byeLifeCredit: CC0 Public DomainResearchers have developed a method that simultaneously measures different cancer-specific hallmarks of DNA circulating in the blood, aiding early detection and l

Updated on:January 12,2024

Trial finds that adagrasib demonstrates durable clinical activity in patients with KRAS-G12C mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe oral, selective KRAS G12C inhibitor KRAS-G12C inhibitor adagrasib demonstrated durable clinical activity,

Updated on: January 04,2024

Trial finds that adagrasib demonstrates durable clinical activity in patients with KRAS-G12C mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe oral, selective KRAS G12C inhibitor KRAS-G12C inhibitor adagrasib demonstrated durable clinical activity,

Updated on:January 04,2024

Women with benign breast disease face higher risk of breast cancer in the long term, according to large-scale study

by European Organisation for Research and Treatment of CancerCumulative incidence rates of breast cancer and 95% confidence intervals in women with and without benign breast disease within year at ind

Updated on: February 03,2024

Women with benign breast disease face higher risk of breast cancer in the long term, according to large-scale study

by European Organisation for Research and Treatment of CancerCumulative incidence rates of breast cancer and 95% confidence intervals in women with and without benign breast disease within year at ind

Updated on:February 03,2024

Study finds cancer cells use a new fuel in absence of sugar

by Anna Megdell,University of MichiganProfiling of metabolite utilization in PDA cells identifies uridine. Credit:Nature(2023). DOI: 10.1038/s41586-023-06073-wResearchers at the Univ

Updated on: January 23,2024

Study finds cancer cells use a new fuel in absence of sugar

by Anna Megdell,University of MichiganProfiling of metabolite utilization in PDA cells identifies uridine. Credit:Nature(2023). DOI: 10.1038/s41586-023-06073-wResearchers at the Univ

Updated on:January 23,2024

New approach combines oncolytic virotherapy and adoptive T cell therapy for cancer treatment

by Bob Yirka , Medical XpressScheme of genome editing of PDL1 by eOA effectively improved virotherapy and adoptive T-cell therapy. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-02

Updated on: March 05,2024

New approach combines oncolytic virotherapy and adoptive T cell therapy for cancer treatment

by Bob Yirka , Medical XpressScheme of genome editing of PDL1 by eOA effectively improved virotherapy and adoptive T-cell therapy. Credit:Nature Biotechnology(2024). DOI: 10.1038/s41587-02

Updated on:March 05,2024

Taxane-induced peripheral neuropathy in breast cancer: Frequent, clinically significant, and worse with paclitaxel

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainChemotherapy-induced peripheral neuropathy (CIPN)—nerve pain, tingling, or numbness in the hands or feet—is a common side effect of cer

Updated on: January 22,2024

Taxane-induced peripheral neuropathy in breast cancer: Frequent, clinically significant, and worse with paclitaxel

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainChemotherapy-induced peripheral neuropathy (CIPN)—nerve pain, tingling, or numbness in the hands or feet—is a common side effect of cer

Updated on:January 22,2024

Eliminating extra chromosomes in cancer cells prevents tumor growth, new study reveals

by Yale UniversityCredit: Pixabay/CC0 Public DomainCancer cells with extra chromosomes depend on those chromosomes for tumor growth, a new Yale study reveals, and eliminating them prevents the ce

Updated on: January 30,2024

Eliminating extra chromosomes in cancer cells prevents tumor growth, new study reveals

by Yale UniversityCredit: Pixabay/CC0 Public DomainCancer cells with extra chromosomes depend on those chromosomes for tumor growth, a new Yale study reveals, and eliminating them prevents the ce

Updated on:January 30,2024

A promising discovery in the fight against incurable cancers

by Katherine Moss,University of KentT cells induce galectin-9 secretion in human cancer cells derived from solid malignant tumors and keratinocytes. (A) Human cancer cells derived from solid mal

Updated on: February 01,2024

A promising discovery in the fight against incurable cancers

by Katherine Moss,University of KentT cells induce galectin-9 secretion in human cancer cells derived from solid malignant tumors and keratinocytes. (A) Human cancer cells derived from solid mal

Updated on:February 01,2024

Fighting cancer on Earth and in space using high-energy protons

byUS Department of EnergyLeft: production rate as a function of proton energy of parent radioisotopes selenium-72 (Se-72) (1) & germanium-68 (Ge-68) (2). Right, a Positron Emission Tomograph

Updated on: December 28,2023

Fighting cancer on Earth and in space using high-energy protons

byUS Department of EnergyLeft: production rate as a function of proton energy of parent radioisotopes selenium-72 (Se-72) (1) & germanium-68 (Ge-68) (2). Right, a Positron Emission Tomograph

Updated on:December 28,2023

Study shows many expensive cancer drugs have unclear patient benefit

byUniversity of GothenburgDiseases targeted in the included trials. Credit:Clinical Drug Investigation(2023). DOI: 10.1007/s40261-023-01285-4New cancer drugs are being launched rapid

Updated on: January 16,2024

Study shows many expensive cancer drugs have unclear patient benefit

byUniversity of GothenburgDiseases targeted in the included trials. Credit:Clinical Drug Investigation(2023). DOI: 10.1007/s40261-023-01285-4New cancer drugs are being launched rapid

Updated on:January 16,2024